Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Alina Fuerea"'
Autor:
Anthony Tarabay, Alice Boileve, Cristina Smolenschi, Leony Antoun, Marine Valery, Alina Fuerea, Audrey Perret, Pascal Burtin, Simona Cosconea, Hichem Belkhodja, David Malka, Valérie Boige, Antoine Hollebecque, Michel Ducreux
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2569 (2023)
Background: Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of death by cancer worldwide. Mostly diagnosed with locally advanced or metastatic disease, patients lack treatment options. Gene alterations (GAs) are frequently observed
Externí odkaz:
https://doaj.org/article/26a3fb018c8542f2bb1c09dce554c516
Autor:
Eugénie Rigault, Benjamin Lacas, Olivier Glehen, Denis Smith, Eric Dupont-Bierre, Rosine Guimbaud, David Malka, Valérie Boige, Alina Fuerea, Jean-Pierre Pignon, Michel Ducreux
Publikováno v:
Cancer Treatment and Research Communications, Vol 34, Iss , Pp 100674- (2023)
Introduction: Intra-arterial hepatic (IAH) treatment has shown promising results in the management of patients with unresectable colorectal liver metastases (CRLM) the prognosis of which is poor. Bevacizumab adjunction to standard chemotherapy has be
Externí odkaz:
https://doaj.org/article/c22bcb3444d34782a25dee5d64cfa6c8
Autor:
Pernelle Lavaud, Clément Dumont, Constance Thibault, Laurence Albiges, Giulia Baciarello, Emeline Colomba, Ronan Flippot, Alina Fuerea, Yohann Loriot, Karim Fizazi
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Until recently, continuing androgen deprivation therapy (ADT) and closely monitoring patients until evolution towards metastatic castration-resistant prostate cancer (CRPC) were recommended in men with non-metastatic CRPC (nmCRPC). Because delaying t
Externí odkaz:
https://doaj.org/article/631263ea1bcb47c7939c497907d7f7ae
Autor:
Ronan, Flippot, Anna, Patrikidou, Mihaela, Aldea, Emeline, Colomba, Pernelle, Lavaud, Laurence, Albigès, Natacha, Naoun, Pierre, Blanchard, Mario, Terlizzi, Camilo, Garcia, Alice, Bernard-Tessier, Alina, Fuerea, Mario, Di Palma, Bernard, Escudier, Yohann, Loriot, Giulia, Baciarello, Karim, Fizazi
Publikováno v:
Drugs. 82:719-733
Up to 25% of patients with metastatic prostate cancer present with germline or somatic DNA damage repair alterations, some of which are associated with aggressive disease and poor outcomes. New data have brought poly(ADP-ribose) polymerase (PARP) inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1398e43dcfe6b26bc901b4e5ad2776dc
https://doi.org/10.1007/s40265-022-01703-5
https://doi.org/10.1007/s40265-022-01703-5
Autor:
Pauline Parent, Edouard Auclin, Anna Patrikidou, Laura Mezquita, Nieves Martínez Chanzá, Clément Dumont, Alejo Rodriguez-Vida, Casilda Llacer, Rebeca Lozano, Raffaele Ratta, Axel S. Merseburger, Cora N. Sternberg, Giulia Baciarello, Emeline Colomba, Alina Fuerea, Benjamin Besse, Yohann Loriot, Pernelle Lavaud
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1066
Volume 15
Issue 4
Pages: 1066
Few prognostic factors have been identified in patients with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs). The Lung Immune Prognostic Index (LIPI) was associated with clinical outcomes for ICIs in several tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::826e45e39501c45ab04417be8cfa629f
Autor:
Marine Valery, Baptiste Cervantes, Ramy Samaha, Maximiliano Gelli, Cristina Smolenschi, Alina Fuerea, Lambros Tselikas, Caroline Klotz-Prieux, Antoine Hollebecque, Valérie Boige, Michel Ducreux
Publikováno v:
Cancers. 14(18)
Immunotherapy has demonstrated its effectiveness in many cancers. In hepatocellular carcinoma (HCC), promising results shown in the first phase II studies evaluating anti-PD-1 or anti-PD-L1 monotherapies resulted in their approval in the United State
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd36b84cd96ca7b09e4cccf524d6b325
https://pubmed.ncbi.nlm.nih.gov/36139683
https://pubmed.ncbi.nlm.nih.gov/36139683
Publikováno v:
Digestive and Liver Disease. 53:1059-1061
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc64d0a168f62e994b8afabcabffdf47
https://doi.org/10.1016/j.dld.2021.04.033
https://doi.org/10.1016/j.dld.2021.04.033
Autor:
Cristina Smolenschi, Marine Valery, Alice Boileve, Baptiste Cervantes, Anthony Tarabay, Valerie Boige, Imen Ben-Ammar, Bianca Cheaib, Maximiliano Gelli, Isabelle Sourouille, Leonor Benhaim, Alina Fuerea, Audrey Perret, Michel Ducreux, Antoine Hollebecque
Publikováno v:
Journal of Clinical Oncology. 41:809-809
809 Background: Peritoneal carcinomatosis (PC) is a common manifestation in gastro-intestinal (GI) cancers.10-20 % of patients (pts) will present isolated, unresectable peritoneal disease with poor prognosis. In the past years, circulating tumor DNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60bc960f8f704399d46f28612d6f0773
https://doi.org/10.1200/jco.2023.41.4_suppl.809
https://doi.org/10.1200/jco.2023.41.4_suppl.809
Autor:
Karim Fizazi, Clément Dumont, Pernelle Lavaud, Ronan Flippot, Giulia Baciarello, Constance Thibault, Yohann Loriot, Alina Fuerea, Laurence Albiges, Emeline Colomba
Publikováno v:
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Until recently, continuing androgen deprivation therapy (ADT) and closely monitoring patients until evolution towards metastatic castration-resistant prostate cancer (CRPC) were recommended in men with non-metastatic CRPC (nmCRPC). Because delaying t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9771956848dd28afaec21dc6b4fbbbfe
https://pubmed.ncbi.nlm.nih.gov/33488778
https://pubmed.ncbi.nlm.nih.gov/33488778
Autor:
Anthony Tarabay, Antoine Hollebecque, Cristina Smolenschi, Leony Antoun, Caroline Klotz, Alina Fuerea, Audrey Perret, Claire Gouriou, Pascal Burtin, Hichem Belkhodja, Valérie Boige, David Malka, Michel Ducreux
Publikováno v:
Journal of Clinical Oncology. 40:605-605
605 Background: Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of death by cancer worldwide. Mostly diagnosed with locally advanced or metastatic disease, patients lack for treatment options. Gene alterations (GAs) are frequently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66bb3f2f6b47042b1e4a4f2a6c84d291
https://doi.org/10.1200/jco.2022.40.4_suppl.605
https://doi.org/10.1200/jco.2022.40.4_suppl.605